
Experimental stroke drug shows potential as treatment for Alzheimer’s
A neuroprotective therapeutic being developed by Australian biotechnology company, Argenica Therapeutics to reduce brain tissue death after stroke may also...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Research group
Keep informed with our latest updates.
Stay up to date with our latest news and announcements.